7 min read
Tirzepatide vs semaglutide: what women should know
Tirzepatide and semaglutide are both medicines used in medical weight management. They work in related but different ways, and the choice between them is a clinical one.
How they differ
Semaglutide acts on the GLP-1 receptor. Tirzepatide acts on both the GLP-1 and GIP receptors. Both are usually taken as a weekly injection, and oral forms exist for some formulations.
Both are started at a low dose and increased gradually, which is why prices are often different at the start and at a maintenance dose.
Common side effects
Nausea, constipation, diarrhea and reduced appetite are the most commonly reported side effects, especially when the dose increases. Your clinician will review your history, including any personal or family history of medullary thyroid cancer, pancreatitis or gallbladder disease.
Why menopause stage matters
Midlife hormone changes affect sleep, muscle mass and where the body stores fat. Some women find it helpful to have one clinician look at both weight and menopause symptoms, rather than treating them separately.
About compounded versions
Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies for an individual prescription. They are not the same as brand-name products and are not FDA-approved.
Questions to bring to a clinician
- Do I meet the criteria for GLP-1 care?
- Which medication and form fits my health history?
- What side effects should I watch for, and when should I call?
- Should my menopause symptoms be part of the plan?
Compounded medications are not FDA-approved. The FDA does not verify the safety, effectiveness, or quality of compounded medications. All treatment decisions are made by a licensed medical provider based on an individual evaluation.
This guide is general education, not medical advice. Talk with a licensed clinician about your own health.
